Clinipace Takes Over Worldwide Clinical Research

Clinipace has closed its acquisition of Worldwide Clinical Research, (WWCR) on October 26th, 2009. With the acquisition, Clinipace has changed its name to Clinipace Worldwide.

Reportedly, with specific expertise in oncology, among other therapeutic areas, the company will offer fully-integrated technology-based clinical research solutions and services to growth-oriented and mid-tier biopharmaceutical and medical device firms.

WWCR currently provides clinical operations functionality including monitoring, site management, and project management. These services will now be augmented by Clinipace’s focus on technology-driven clinical research solutions to provide clients with full-service, global research services that result in greater trial visibility, more project control, and lower costs.

Barbara Geiger, president and CEO of WWCR, is expected to transition to executive vice president of Clinical Operations and will be responsible for directing all clinical operations for Clinipace Worldwide.

Jeff Williams, CEO at Clinipace, said: “Having honed our expertise on electronic data management services, we felt it was critical to expand both our clinical operations expertise and global presence in order to support our growth. WWCR’s reliable service, global access to enrolling sites, and program-level therapeutic experience will be a natural complement to our existing research model and global expansion strategy.”

Barb Geiger, executive vice president of Clinical Operations, said: “By combining forces, we can better serve our clients with a fully-integrated end-to-end development solution and expert services. The synergies between WWCR and Clinipace will provide our clients with a complete range of technology-driven services, ranging from clinical operations all the way through regulatory submission.”